{
    "medicine_id": "b5da806521fc2065e1b8bfa81d76eeac59cb16a8",
    "platform_id": "DB00261",
    "metadata": {
        "name": "Agrylin 1 mg 1 Capsule",
        "composition": "1 mg 1 Anagrelide",
        "clinical_particulars": {
            "therapeutic_indications": "Anagrelide is indicated for the treatment of thrombocythemia secondary to malignant neoplasms to reduce platelet count and the associated risk of thrombosis It is also beneficial in the amelioration of thrombocythemia symptoms including thrombo hemorrhagic events L14153",
            "contraindications": {
                "disease": "The oral LD sub 50 sub of anagrelide as reported in rats and mice is 1500mg kg and 2500mg kg respectively L14243 Symptoms of overdose may include hypotension sinus tachycardia and vomiting As the therapeutic effect of anagrelide i e platelet reduction is dose related significant thrombocytopenia is expected in instances of overdose L14153 Treatment of overdose should involve careful monitoring of platelet counts and complications such as bleeding L14153 Employ symptomatic and supportive measures if clinically indicated",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Anagrelide decreases platelet counts by suppressing transcription factors necessary for the synthesis and maturation of platelet producing cells L14153 The drug itself appears to have a relatively short residence time in the body necessitating twice or four times daily dosing However given that the pharmacological effect of anagrelide therapy is reliant on a gradual suppression of platelet producing cells it may take 7 to 14 days L14300 for its administration to be reflected in reduced platelet counts for this reason any changes to anagrelide doses should not exceed 0 5 mg day in any one week L14153 Evidence from animal studies suggests anagrelide may impair female fertility L14153 Female patients of reproductive age should be advised of the potential for adverse effects on fertility prior to initiating therapy",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00697",
                        "description": "The serum concentration of Tizanidine can be increased when it is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Apixaban"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "Dasatinib may increase the anticoagulant activities of Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01586",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Ursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB02123",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Glycochenodeoxycholic Acid"
                    },
                    {
                        "drugbank-id": "DB02659",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Cholic Acid"
                    },
                    {
                        "drugbank-id": "DB02691",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Glycocholic acid"
                    },
                    {
                        "drugbank-id": "DB03619",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Deoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB04348",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Taurocholic acid"
                    },
                    {
                        "drugbank-id": "DB06777",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Chenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08833",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08834",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08857",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Bamet UD2"
                    },
                    {
                        "drugbank-id": "DB11622",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Dehydrocholic acid"
                    },
                    {
                        "drugbank-id": "DB11789",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Hyodeoxycholic Acid"
                    },
                    {
                        "drugbank-id": "DB01296",
                        "description": "Glucosamine may increase the antiplatelet activities of Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00078",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Ibritumomab tiuxetan"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The risk or severity of adverse effects can be increased when Ibrutinib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "Pentoxifylline may increase the antiplatelet activities of Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "Anagrelide may increase the anticoagulant activities of Rivaroxaban"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "Tipranavir may increase the antiplatelet activities of Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00013",
                        "description": "Anagrelide may increase the anticoagulant activities of Urokinase"
                    },
                    {
                        "drugbank-id": "DB00163",
                        "description": "Vitamin E may increase the antiplatelet activities of Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The serum concentration of Anagrelide can be increased when it is combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The serum concentration of Anagrelide can be increased when it is combined with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "The serum concentration of Anagrelide can be decreased when it is combined with Leflunomide"
                    },
                    {
                        "drugbank-id": "DB08880",
                        "description": "The serum concentration of Anagrelide can be decreased when it is combined with Teriflunomide"
                    },
                    {
                        "drugbank-id": "DB00235",
                        "description": "The risk or severity of congestive heart failure bleeding hypotension and Tachycardia can be increased when Milrinone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of congestive heart failure bleeding hypotension and Tachycardia can be increased when Anagrelide is combined with Cilostazol"
                    },
                    {
                        "drugbank-id": "DB01427",
                        "description": "The risk or severity of congestive heart failure bleeding hypotension and Tachycardia can be increased when Anagrelide is combined with Amrinone"
                    },
                    {
                        "drugbank-id": "DB04880",
                        "description": "The risk or severity of congestive heart failure bleeding hypotension and Tachycardia can be increased when Anagrelide is combined with Enoximone"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The metabolism of Zolmitriptan can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Anagrelide may increase the hypotensive activities of Riociguat"
                    },
                    {
                        "drugbank-id": "DB00686",
                        "description": "The risk or severity of adverse effects can be increased when Pentosan polysulfate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB05812",
                        "description": "The serum concentration of Anagrelide can be increased when it is combined with Abiraterone"
                    },
                    {
                        "drugbank-id": "DB09211",
                        "description": "Limaprost may increase the antiplatelet activities of Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11133",
                        "description": "Omega 3 fatty acids may increase the antiplatelet activities of Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "The metabolism of Anagrelide can be increased when combined with Cyproterone acetate"
                    },
                    {
                        "drugbank-id": "DB00054",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00001",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Lepirudin"
                    },
                    {
                        "drugbank-id": "DB00006",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Bivalirudin"
                    },
                    {
                        "drugbank-id": "DB00009",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Alteplase"
                    },
                    {
                        "drugbank-id": "DB00015",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Reteplase"
                    },
                    {
                        "drugbank-id": "DB00029",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Anistreplase"
                    },
                    {
                        "drugbank-id": "DB00031",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Tenecteplase"
                    },
                    {
                        "drugbank-id": "DB00055",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Drotrecogin alfa"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Streptokinase"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00278",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Argatroban"
                    },
                    {
                        "drugbank-id": "DB00407",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Ardeparin"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Fondaparinux"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Dipyridamole"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Iloprost"
                    },
                    {
                        "drugbank-id": "DB01109",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Heparin"
                    },
                    {
                        "drugbank-id": "DB01225",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Enoxaparin"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB04898",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Ximelagatran"
                    },
                    {
                        "drugbank-id": "DB04925",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Desmoteplase"
                    },
                    {
                        "drugbank-id": "DB04932",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Defibrotide"
                    },
                    {
                        "drugbank-id": "DB05099",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Ancrod"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Beraprost"
                    },
                    {
                        "drugbank-id": "DB05254",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Fibrinolysin"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Prasugrel"
                    },
                    {
                        "drugbank-id": "DB06271",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Sulodexide"
                    },
                    {
                        "drugbank-id": "DB06294",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Semuloparin"
                    },
                    {
                        "drugbank-id": "DB06406",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Idraparinux"
                    },
                    {
                        "drugbank-id": "DB06441",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Cangrelor"
                    },
                    {
                        "drugbank-id": "DB06543",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Astaxanthin"
                    },
                    {
                        "drugbank-id": "DB06635",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Otamixaban"
                    },
                    {
                        "drugbank-id": "DB06679",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Amediplase"
                    },
                    {
                        "drugbank-id": "DB06754",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Danaparoid"
                    },
                    {
                        "drugbank-id": "DB06779",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Dalteparin"
                    },
                    {
                        "drugbank-id": "DB06822",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Tinzaparin"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB08813",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Nadroparin"
                    },
                    {
                        "drugbank-id": "DB08814",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Triflusal"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Ticagrelor"
                    },
                    {
                        "drugbank-id": "DB08994",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Ditazole"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Potassium citrate"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Sodium citrate"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Dextran"
                    },
                    {
                        "drugbank-id": "DB09258",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Bemiparin"
                    },
                    {
                        "drugbank-id": "DB09260",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Parnaparin"
                    },
                    {
                        "drugbank-id": "DB11095",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Desirudin"
                    },
                    {
                        "drugbank-id": "DB11154",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Zinc citrate"
                    },
                    {
                        "drugbank-id": "DB11166",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Antithrombin Alfa"
                    },
                    {
                        "drugbank-id": "DB11312",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Protein C"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Antithrombin III human"
                    },
                    {
                        "drugbank-id": "DB11984",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Letaxaban"
                    },
                    {
                        "drugbank-id": "DB12289",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Darexaban"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Betrixaban"
                    },
                    {
                        "drugbank-id": "DB12598",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12726",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Monteplase"
                    },
                    {
                        "drugbank-id": "DB12831",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Gabexate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13149",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13199",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Brinase"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB13616",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Melagatran"
                    },
                    {
                        "drugbank-id": "DB13646",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Saruplase"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB14598",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Edetate calcium disodium anhydrous"
                    },
                    {
                        "drugbank-id": "DB14726",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Dabigatran"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Vorapaxar"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Edoxaban"
                    },
                    {
                        "drugbank-id": "DB13124",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Troxerutin"
                    },
                    {
                        "drugbank-id": "DB00974",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Edetic acid"
                    },
                    {
                        "drugbank-id": "DB09259",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Reviparin"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Goserelin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of QTc prolongation can be increased when Methadone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of QTc prolongation can be increased when Clozapine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Promazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Droperidol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of QTc prolongation can be increased when Imipramine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Perflutren is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of QTc prolongation can be increased when Cinnarizine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The risk or severity of QTc prolongation can be increased when Propranolol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Atropine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Efavirenz is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Adenosine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Pentamidine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Carbinoxamine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Roxithromycin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Cinoxacin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The risk or severity of QTc prolongation can be increased when Loperamide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Granisetron is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Telithromycin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Primaquine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Papaverine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The risk or severity of QTc prolongation can be increased when Propafenone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The risk or severity of QTc prolongation can be increased when Flecainide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Levacetylmethadol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Probucol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluspirilene is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Azimilide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Technetium Tc 99m ciprofloxacin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Garenoxacin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Telavancin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Antazoline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Fendiline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of QTc prolongation can be increased when Eperisone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of QTc prolongation can be increased when Melperone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Benidipine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Entinostat is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when CUDC 101 is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Ricolinostat is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Mizolastine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Sitafloxacin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Sultopride is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation can be increased when Otilonium is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Nizofenone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Bunaftine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Lorcainide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of QTc prolongation can be increased when Penfluridol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Ivosidenib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The risk or severity of QTc prolongation can be increased when Indenolol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Simendan is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Encorafenib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Emedastine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The risk or severity of QTc prolongation can be increased when Berotralstat is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The risk or severity of QTc prolongation can be increased when Esmolol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Isradipine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The risk or severity of QTc prolongation can be increased when Timolol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The risk or severity of QTc prolongation can be increased when Digoxin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Losartan is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of QTc prolongation can be increased when Moricizine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of QTc prolongation can be increased when Risperidone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indapamide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Formoterol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The risk or severity of QTc prolongation can be increased when Felodipine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of QTc prolongation can be increased when Promethazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The risk or severity of QTc prolongation can be increased when Encainide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Cariporide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Degarelix is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Buserelin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Histrelin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Eribulin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Famphur is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Fenthion is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Phosmet is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Bilastine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Ebastine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The risk or severity of QTc prolongation can be increased when Talinolol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when CUDC 907 is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Temefos is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Givinostat is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of QTc prolongation can be increased when Aripiprazole lauroxil is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Inotersen is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of QTc prolongation can be increased when Desipramine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Anagrelide can be increased when combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The metabolism of Anagrelide can be increased when combined with Primidone"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The metabolism of Anagrelide can be increased when combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Sotalol"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Astemizole"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Procainamide"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Ivabradine"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Citalopram is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Quinidine"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The serum concentration of Anagrelide can be decreased when it is combined with Osimertinib"
                    },
                    {
                        "drugbank-id": "DB00063",
                        "description": "Eptifibatide may increase the antiplatelet activities of Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "Anagrelide may increase the antiplatelet activities of Clopidogrel"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "Anagrelide may increase the antiplatelet activities of Tirofiban"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "Anagrelide may increase the antiplatelet activities of Sulfinpyrazone"
                    },
                    {
                        "drugbank-id": "DB01207",
                        "description": "Anagrelide may increase the antiplatelet activities of Ridogrel"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "Anagrelide may increase the antiplatelet activities of Tesmilifene"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "Anagrelide may increase the antiplatelet activities of Ibudilast"
                    },
                    {
                        "drugbank-id": "DB05767",
                        "description": "Anagrelide may increase the antiplatelet activities of Andrographolide"
                    },
                    {
                        "drugbank-id": "DB06081",
                        "description": "Anagrelide may increase the antiplatelet activities of Caplacizumab"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "Anagrelide may increase the antiplatelet activities of Tranilast"
                    },
                    {
                        "drugbank-id": "DB08887",
                        "description": "Anagrelide may increase the antiplatelet activities of Icosapent ethyl"
                    },
                    {
                        "drugbank-id": "DB09283",
                        "description": "Anagrelide may increase the antiplatelet activities of Trapidil"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "Anagrelide may increase the antiplatelet activities of Naftopidil"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "Anagrelide may increase the antiplatelet activities of Sarpogrelate"
                    },
                    {
                        "drugbank-id": "DB12321",
                        "description": "Anagrelide may increase the antiplatelet activities of Ifetroban"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "Anagrelide may increase the antiplatelet activities of Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12749",
                        "description": "Anagrelide may increase the antiplatelet activities of Butylphthalide"
                    },
                    {
                        "drugbank-id": "DB12771",
                        "description": "Anagrelide may increase the antiplatelet activities of Hydroxytyrosol"
                    },
                    {
                        "drugbank-id": "DB13036",
                        "description": "Anagrelide may increase the antiplatelet activities of Ramatroban"
                    },
                    {
                        "drugbank-id": "DB13327",
                        "description": "Anagrelide may increase the antiplatelet activities of Picotamide"
                    },
                    {
                        "drugbank-id": "DB13367",
                        "description": "Anagrelide may increase the antiplatelet activities of Cloricromen"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "Anagrelide may increase the antiplatelet activities of Linsidomine"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "Anagrelide may increase the antiplatelet activities of Buflomedil"
                    },
                    {
                        "drugbank-id": "DB13929",
                        "description": "Anagrelide may increase the antiplatelet activities of Relcovaptan"
                    },
                    {
                        "drugbank-id": "DB00233",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Aminosalicylic acid"
                    },
                    {
                        "drugbank-id": "DB01294",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB06251",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Dersalazine"
                    },
                    {
                        "drugbank-id": "DB06807",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Phenyl aminosalicylate"
                    },
                    {
                        "drugbank-id": "DB09543",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Methyl salicylate"
                    },
                    {
                        "drugbank-id": "DB13509",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Aloxiprin"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Choline salicylate"
                    },
                    {
                        "drugbank-id": "DB14026",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Thiosalicylic acid"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "Anagrelide may increase the anticoagulant activities of Dabigatran etexilate"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Aldesleukin"
                    },
                    {
                        "drugbank-id": "DB00056",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Gemtuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB00073",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Rituximab"
                    },
                    {
                        "drugbank-id": "DB00087",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Alemtuzumab"
                    },
                    {
                        "drugbank-id": "DB00120",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Phenylalanine"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Cladribine"
                    },
                    {
                        "drugbank-id": "DB00276",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Amsacrine"
                    },
                    {
                        "drugbank-id": "DB00291",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Chlorambucil"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Raltitrexed"
                    },
                    {
                        "drugbank-id": "DB00305",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Mitomycin"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Bexarotene"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Vindesine"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Floxuridine"
                    },
                    {
                        "drugbank-id": "DB00352",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Tioguanine"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Dexrazoxane"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Gemcitabine"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Teniposide"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Chloramphenicol"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Lenalidomide"
                    },
                    {
                        "drugbank-id": "DB00488",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Altretamine"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Zidovudine"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Cisplatin"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Pentostatin"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Methotrexate"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Clofarabine"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Daunorubicin"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Irinotecan"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Temozolomide"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Penicillamine"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Sirolimus"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Mechlorethamine"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Azacitidine"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Carboplatin"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Dactinomycin"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Cytarabine"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Hydroxyurea"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Busulfan"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Topotecan"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Mercaptopurine"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Thalidomide"
                    },
                    {
                        "drugbank-id": "DB01042",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Melphalan"
                    },
                    {
                        "drugbank-id": "DB01073",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Fludarabine"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Flucytosine"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Capecitabine"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Idarubicin"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01206",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Lomustine"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Paclitaxel"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Docetaxel"
                    },
                    {
                        "drugbank-id": "DB01262",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Decitabine"
                    },
                    {
                        "drugbank-id": "DB01280",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Nelarabine"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Thiotepa"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Ixabepilone"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Trabectedin"
                    },
                    {
                        "drugbank-id": "DB05472",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Human interferon omega 1"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Trastuzumab emtansine"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Bosutinib"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Cabazitaxel"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Ruxolitinib"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Tofacitinib"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB09042",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Tedizolid phosphate"
                    },
                    {
                        "drugbank-id": "DB09052",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Blinatumomab"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Palbociclib"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Olaparib"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Dinutuximab"
                    },
                    {
                        "drugbank-id": "DB00445",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Epirubicin"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Propylthiouracil"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Ifosfamide"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The serum concentration of Anagrelide can be increased when it is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Anagrelide may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB13967",
                        "description": "The therapeutic efficacy of Anagrelide can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of hemorrhage can be increased when Duloxetine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of hemorrhage can be increased when Paroxetine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of hemorrhage can be increased when Sibutramine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of hemorrhage can be increased when Nefazodone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of hemorrhage can be increased when Zimelidine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of hemorrhage can be increased when Milnacipran is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of hemorrhage can be increased when Seproxetine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of hemorrhage can be increased when Indalpine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of hemorrhage can be increased when Ritanserin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of hemorrhage can be increased when Alaproclate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Nicotine"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "The metabolism of Carmustine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00296",
                        "description": "The metabolism of Ropivacaine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The metabolism of Acetaminophen can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The metabolism of Chlorzoxazone can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00382",
                        "description": "The metabolism of Tacrine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "The metabolism of Triamterene can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "The metabolism of Zolpidem can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00442",
                        "description": "The metabolism of Entecavir can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "The metabolism of Flutamide can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00518",
                        "description": "The metabolism of Albendazole can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "The metabolism of Guanabenz can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The metabolism of Pemetrexed can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "The metabolism of Riluzole can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00744",
                        "description": "The metabolism of Zileuton can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "The metabolism of Acyclovir can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The metabolism of Trifluoperazine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The metabolism of Perphenazine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Terbinafine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The metabolism of Ranitidine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "The metabolism of Ramelteon can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "The metabolism of Azathioprine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The metabolism of Frovatriptan can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01002",
                        "description": "The metabolism of Levobupivacaine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01012",
                        "description": "The metabolism of Cinacalcet can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01058",
                        "description": "The metabolism of Praziquantel can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01065",
                        "description": "The metabolism of Melatonin can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01094",
                        "description": "The metabolism of Hesperetin can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The metabolism of Carvedilol can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The metabolism of Dexfenfluramine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01303",
                        "description": "The metabolism of Oxtriphylline can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "The metabolism of Theobromine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01482",
                        "description": "The metabolism of Fenethylline can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "The metabolism of Bromazepam can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01667",
                        "description": "The metabolism of 8 azaguanine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB02134",
                        "description": "The metabolism of Xanthine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB02489",
                        "description": "The metabolism of 9 Methylguanine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB02568",
                        "description": "The metabolism of Peldesine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB03783",
                        "description": "The metabolism of Phenacetin can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04076",
                        "description": "The metabolism of Hypoxanthine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04356",
                        "description": "The metabolism of 9 Deazaguanine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The metabolism of Flunarizine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The metabolism of Lorcaserin can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The metabolism of Mianserin can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "The metabolism of Eltrombopag can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06235",
                        "description": "The metabolism of Vadimezan can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06479",
                        "description": "The metabolism of Propentofylline can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06594",
                        "description": "The metabolism of Agomelatine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The metabolism of Benzyl alcohol can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "The metabolism of Perampanel can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The metabolism of Tasimelteon can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "The metabolism of Zotepine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09290",
                        "description": "The metabolism of Ramosetron can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11919",
                        "description": "The metabolism of 6 O benzylguanine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11967",
                        "description": "The metabolism of Binimetinib can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "The metabolism of Voxilaprevir can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12406",
                        "description": "The metabolism of Lisofylline can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12531",
                        "description": "The metabolism of Lobucavir can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12926",
                        "description": "The metabolism of Cafedrine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The metabolism of Theodrenaline can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13203",
                        "description": "The metabolism of Bamifylline can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13449",
                        "description": "The metabolism of Proxyphylline can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13573",
                        "description": "The metabolism of Acefylline can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13592",
                        "description": "The metabolism of Etamiphylline can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13634",
                        "description": "The metabolism of Pentifylline can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13812",
                        "description": "The metabolism of Bufylline can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "The metabolism of Bromotheophylline can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB14132",
                        "description": "The metabolism of 8 chlorotheophylline can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The metabolism of Istradefylline can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "The metabolism of Azelastine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04889",
                        "description": "The metabolism of Bicifadine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB05708",
                        "description": "The metabolism of GTS 21 can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The metabolism of Doxepin can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The metabolism of Mephenytoin can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "The metabolism of Cyclobenzaprine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "The metabolism of Selumetinib can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The metabolism of Verapamil can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "The metabolism of Estradiol can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "The metabolism of Ethanol can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The metabolism of Ethinylestradiol can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The metabolism of Doxofylline can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "The metabolism of Estrone can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00299",
                        "description": "The metabolism of Penciclovir can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04951",
                        "description": "The metabolism of Pirfenidone can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Enoxacin"
                    },
                    {
                        "drugbank-id": "DB00549",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Zafirlukast"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB14025",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Clinafloxacin"
                    },
                    {
                        "drugbank-id": "DB14029",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Furafylline"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The metabolism of Rucaparib can be increased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The metabolism of Belinostat can be increased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00030",
                        "description": "The metabolism of Anagrelide can be increased when combined with Insulin human"
                    },
                    {
                        "drugbank-id": "DB00046",
                        "description": "The metabolism of Anagrelide can be increased when combined with Insulin lispro"
                    },
                    {
                        "drugbank-id": "DB00047",
                        "description": "The metabolism of Anagrelide can be increased when combined with Insulin glargine"
                    },
                    {
                        "drugbank-id": "DB00071",
                        "description": "The metabolism of Anagrelide can be increased when combined with Insulin pork"
                    },
                    {
                        "drugbank-id": "DB00170",
                        "description": "The metabolism of Anagrelide can be increased when combined with Menadione"
                    },
                    {
                        "drugbank-id": "DB00400",
                        "description": "The metabolism of Anagrelide can be increased when combined with Griseofulvin"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The metabolism of Anagrelide can be increased when combined with Secobarbital"
                    },
                    {
                        "drugbank-id": "DB00428",
                        "description": "The metabolism of Anagrelide can be increased when combined with Streptozocin"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The metabolism of Anagrelide can be increased when combined with Meperidine"
                    },
                    {
                        "drugbank-id": "DB00607",
                        "description": "The metabolism of Anagrelide can be increased when combined with Nafcillin"
                    },
                    {
                        "drugbank-id": "DB00745",
                        "description": "The metabolism of Anagrelide can be increased when combined with Modafinil"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The metabolism of Anagrelide can be increased when combined with Rabeprazole"
                    },
                    {
                        "drugbank-id": "DB01309",
                        "description": "The metabolism of Anagrelide can be increased when combined with Insulin glulisine"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The metabolism of Anagrelide can be increased when combined with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB05115",
                        "description": "The metabolism of Anagrelide can be increased when combined with NN344"
                    },
                    {
                        "drugbank-id": "DB05928",
                        "description": "The metabolism of Anagrelide can be increased when combined with Dovitinib"
                    },
                    {
                        "drugbank-id": "DB06413",
                        "description": "The metabolism of Anagrelide can be increased when combined with Armodafinil"
                    },
                    {
                        "drugbank-id": "DB06732",
                        "description": "The metabolism of Anagrelide can be increased when combined with beta Naphthoflavone"
                    },
                    {
                        "drugbank-id": "DB09564",
                        "description": "The metabolism of Anagrelide can be increased when combined with Insulin degludec"
                    },
                    {
                        "drugbank-id": "DB11567",
                        "description": "The metabolism of Anagrelide can be increased when combined with Insulin peglispro"
                    },
                    {
                        "drugbank-id": "DB11568",
                        "description": "The metabolism of Anagrelide can be increased when combined with Insulin tregopil"
                    },
                    {
                        "drugbank-id": "DB06774",
                        "description": "The metabolism of Capsaicin can be increased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09456",
                        "description": "The metabolism of Insulin beef can be increased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The metabolism of Anagrelide can be increased when combined with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The metabolism of Anagrelide can be increased when combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The metabolism of Anagrelide can be increased when combined with Phenylephrine"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Gatifloxacin"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Dosulepin"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Pazufloxacin"
                    },
                    {
                        "drugbank-id": "DB00201",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Caffeine"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Lidocaine"
                    },
                    {
                        "drugbank-id": "DB00379",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Mexiletine"
                    },
                    {
                        "drugbank-id": "DB00969",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Alosetron"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Simeprevir"
                    },
                    {
                        "drugbank-id": "DB09198",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Lobeglitazone"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Famotidine"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Theophylline can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01223",
                        "description": "The metabolism of Aminophylline can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Cimetidine"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Viloxazine"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The metabolism of Etoposide can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "The metabolism of Dacarbazine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01056",
                        "description": "The metabolism of Tocainide can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01645",
                        "description": "The metabolism of Genistein can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The metabolism of Axitinib can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The metabolism of Bendamustine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "The metabolism of Tegafur can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Nevirapine"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "The metabolism of Conjugated estrogens can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The metabolism of Clonidine can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Pefloxacin"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Rosoxacin"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Propofol"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Norfloxacin"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Flumequine"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Orbifloxacin"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Sarafloxacin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Difloxacin"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The metabolism of Cepeginterferon alfa 2B can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Selegiline"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Medical Cannabis can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The metabolism of Nabiximols can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Peginterferon alfa 2a"
                    },
                    {
                        "drugbank-id": "DB00011",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Interferon alfa n1"
                    },
                    {
                        "drugbank-id": "DB00018",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Interferon alfa n3"
                    },
                    {
                        "drugbank-id": "DB00033",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Interferon gamma 1b"
                    },
                    {
                        "drugbank-id": "DB00034",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Interferon alfa 2a Recombinant"
                    },
                    {
                        "drugbank-id": "DB00060",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Interferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB00068",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Interferon beta 1b"
                    },
                    {
                        "drugbank-id": "DB00069",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Interferon alfacon 1"
                    },
                    {
                        "drugbank-id": "DB00105",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Interferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Nitric Oxide"
                    },
                    {
                        "drugbank-id": "DB00553",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Methoxsalen"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Dexmedetomidine"
                    },
                    {
                        "drugbank-id": "DB00730",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Thiabendazole"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Isoniazid"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Gemfibrozil"
                    },
                    {
                        "drugbank-id": "DB05396",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Albinterferon Alfa 2B"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Dapagliflozin"
                    },
                    {
                        "drugbank-id": "DB06803",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Niclosamide"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Peginterferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB11198",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Peppermint oil"
                    },
                    {
                        "drugbank-id": "DB11404",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Enrofloxacin"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB11994",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Diacerein"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Dihydralazine"
                    },
                    {
                        "drugbank-id": "DB13174",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Rhein"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Estradiol dienanthate"
                    },
                    {
                        "drugbank-id": "DB13975",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Black cohosh"
                    },
                    {
                        "drugbank-id": "DB15119",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Ropeginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB15131",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Interferon alfa 2c"
                    },
                    {
                        "drugbank-id": "DB06442",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Avasimibe"
                    },
                    {
                        "drugbank-id": "DB14635",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Curcumin sulfate"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Anagrelide can be decreased when combined with Ticlopidine"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The metabolism of Resveratrol can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "The metabolism of Estrone sulfate can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "The metabolism of Estradiol acetate can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "The metabolism of Estradiol benzoate can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "The metabolism of Estradiol cypionate can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "The metabolism of Estradiol valerate can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB05258",
                        "description": "The metabolism of Interferon alfa can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Anagrelide can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Anagrelide can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Anagrelide can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Anagrelide can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Anagrelide can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Anagrelide can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Anagrelide can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Anagrelide can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Anagrelide can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Anagrelide can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Anagrelide can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Anagrelide can be increased when combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Anagrelide can be increased when combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Anagrelide can be increased when combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Anagrelide can be increased when combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The risk or severity of Tachycardia can be increased when Phentermine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of Tachycardia can be increased when Tramadol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "The risk or severity of Tachycardia can be increased when Trospium is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "The risk or severity of Tachycardia can be increased when Midodrine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "The risk or severity of Tachycardia can be increased when Isoetharine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Etomidate"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Ipratropium"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Metixene"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Norepinephrine"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Trihexyphenidyl"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Oxyphencyclimine"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Procyclidine"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Profenamine"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Phenylpropanolamine"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Methscopolamine bromide"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Dronabinol"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Gallamine triethiodide"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Nabilone"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Darifenacin"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Tridihexethyl"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Triflupromazine"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Anisotropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Metaraminol"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Epinephrine"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Pirenzepine"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Methoxamine"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Homatropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Rocuronium"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Scopolamine"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Benzquinamide"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Clidinium"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Propantheline"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Dicyclomine"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Biperiden"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Orciprenaline"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Phenmetrazine"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Dobutamine"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Pseudoephedrine"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Benzphetamine"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Ritodrine"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Remifentanil"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Bitolterol"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Oxymetazoline"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Diethylpropion"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Methantheline"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Cycrimine"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Glycopyrronium"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Dopamine"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Isoprenaline"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Arbutamine"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Flavoxate"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Pergolide"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Ketamine"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Mivacurium"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Diphenidol"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Ergometrine"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Lisdexamfetamine"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Fenoterol"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Pirbuterol"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Metocurine"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Pancuronium"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Pipecuronium"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Ephedra sinica root"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Ephedrine"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Mephentermine"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Procaterol"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Clenbuterol"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Bambuterol"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Tiotropium"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with MMDA"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Midomafetamine"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with 2 5 Dimethoxy 4 ethylamphetamine"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with 4 Methoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with 4 Bromo 2 5 dimethoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Tenamfetamine"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Chlorphentermine"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Dextroamphetamine"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Metamfetamine"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Phendimetrazine"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Isopropamide"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Mepenzolate"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Amibegron"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Nylidrin"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Rimonabant"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Solabegron"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Droxidopa"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Xylometazoline"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Fesoterodine"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Isometheptene"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Levonordefrin"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Naphazoline"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Tetryzoline"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Hexocyclium"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Protokylol"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Dimetindene"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Tyramine"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Aclidinium"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Adrafinil"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Isoxsuprine"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Hexoprenaline"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Etilefrine"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Dexetimide"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Benactyzine"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Umeclidinium"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Cirazoline"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Synephrine"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Imidafenacin"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Butylscopolamine"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Iofetamine I 123"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Racepinephrine"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Thonzylamine"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with DL Methylephedrine"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Methscopolamine"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Amitraz"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Medetomidine"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Xylazine"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Ractopamine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Romifidine"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Detomidine"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Etafedrine"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Esketamine"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with PF 00610355"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with GW842166"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Ritobegron"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Oxitropium"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Abediterol"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Ajulemic acid"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Tulobuterol"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Dopexamine"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Mebeverine"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Ibipinabant"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Higenamine"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Reproterol"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Tramazoline"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Surinabant"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Mephedrone"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Octopamine"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Tropatepine"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Prifinium"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Fenozolone"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Piperidolate"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Benzilone"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Norfenefrine"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Difemerine"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Oxyfedrine"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Phenglutarimide"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Mazaticol"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Etybenzatropine"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Emepronium"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Poldine"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Bevonium"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Rimiterol"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Rociverine"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Bornaprine"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Methoxyphenamine"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Etanautine"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Tiemonium iodide"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Dihexyverine"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Tretoquinol"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Penthienate"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Gepefrine"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Diphemanil"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Camylofin"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Fenpiverinium"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Emetonium iodide"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Prenalterol"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Xamoterol"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Pipenzolate"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Timepidium"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Mefenorex"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with 2 5 Dimethoxy 4 ethylthioamphetamine"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with WIN 55212 2"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Palmidrol"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "The risk or severity of Tachycardia can be increased when Bethanidine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Labetalol"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Propiomazine"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Guanfacine"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Pizotifen"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Moxonidine"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Rilmenidine"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Propiverine"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "The risk or severity of Tachycardia can be increased when Anagrelide is combined with Chlorphenoxamine"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Ropinirole"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09539",
                        "description": "The risk or severity of bleeding can be increased when Omega 3 acid ethyl esters is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The risk or severity of bleeding can be increased when Ibuprofen is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The risk or severity of bleeding can be increased when Dexibuprofen is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Nimesulide"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Nitroaspirin"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Indobufen"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Mesalazine"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Sulfasalazine"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Diflunisal"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Salicylic acid"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Balsalazide"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Olsalazine"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Guacetisal"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Carbaspirin calcium"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Indomethacin"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Nabumetone"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Rofecoxib"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Diclofenac"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Naproxen"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Aminophenazone"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Antipyrine"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Etoricoxib"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Propacetamol"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The risk or severity of bleeding can be increased when Icosapent is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The risk or severity of bleeding can be increased when Ketorolac is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The risk or severity of bleeding can be increased when Tenoxicam is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The risk or severity of bleeding can be increased when Celecoxib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The risk or severity of bleeding can be increased when Tolmetin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The risk or severity of bleeding can be increased when Piroxicam is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The risk or severity of bleeding can be increased when Fenoprofen is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "The risk or severity of bleeding can be increased when Valdecoxib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The risk or severity of bleeding can be increased when Sulindac is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The risk or severity of bleeding can be increased when Flurbiprofen is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The risk or severity of bleeding can be increased when Etodolac is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The risk or severity of bleeding can be increased when Mefenamic acid is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The risk or severity of bleeding can be increased when Phenylbutazone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The risk or severity of bleeding can be increased when Meloxicam is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The risk or severity of bleeding can be increased when Carprofen is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The risk or severity of bleeding can be increased when Meclofenamic acid is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The risk or severity of bleeding can be increased when Oxaprozin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The risk or severity of bleeding can be increased when Ketoprofen is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "The risk or severity of bleeding can be increased when Lumiracoxib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The risk or severity of bleeding can be increased when Magnesium salicylate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The risk or severity of bleeding can be increased when Salsalate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The risk or severity of bleeding can be increased when Choline magnesium trisalicylate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The risk or severity of bleeding can be increased when Antrafenine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The risk or severity of bleeding can be increased when Tiaprofenic acid is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "The risk or severity of bleeding can be increased when Taxifolin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "The risk or severity of bleeding can be increased when Oxyphenbutazone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04725",
                        "description": "The risk or severity of bleeding can be increased when Licofelone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "The risk or severity of bleeding can be increased when Benoxaprofen is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The risk or severity of bleeding can be increased when Metamizole is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "The risk or severity of bleeding can be increased when Zomepirac is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "The risk or severity of bleeding can be increased when Cimicoxib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The risk or severity of bleeding can be increased when Lornoxicam is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The risk or severity of bleeding can be increased when Aceclofenac is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "The risk or severity of bleeding can be increased when Zaltoprofen is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "The risk or severity of bleeding can be increased when Azapropazone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "The risk or severity of bleeding can be increased when Parecoxib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "The risk or severity of bleeding can be increased when Salicylamide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "The risk or severity of bleeding can be increased when Kebuzone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "The risk or severity of bleeding can be increased when Isoxicam is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "The risk or severity of bleeding can be increased when Indoprofen is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "The risk or severity of bleeding can be increased when Ibuproxam is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "The risk or severity of bleeding can be increased when Floctafenine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "The risk or severity of bleeding can be increased when Fenbufen is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "The risk or severity of bleeding can be increased when Etofenamate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "The risk or severity of bleeding can be increased when Epirizole is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "The risk or severity of bleeding can be increased when Benzydamine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The risk or severity of bleeding can be increased when Dexketoprofen is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The risk or severity of bleeding can be increased when Droxicam is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of bleeding can be increased when Tolfenamic acid is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "The risk or severity of bleeding can be increased when Firocoxib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "The risk or severity of bleeding can be increased when Clonixin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "The risk or severity of bleeding can be increased when Morniflumate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "The risk or severity of bleeding can be increased when Talniflumate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "The risk or severity of bleeding can be increased when Robenacoxib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of bleeding can be increased when Tepoxalin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "The risk or severity of bleeding can be increased when Flunixin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12399",
                        "description": "The risk or severity of bleeding can be increased when Polmacoxib is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "The risk or severity of bleeding can be increased when Ebselen is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "The risk or severity of bleeding can be increased when Tinoridine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "The risk or severity of bleeding can be increased when Alclofenac is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "The risk or severity of bleeding can be increased when Fentiazac is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "The risk or severity of bleeding can be increased when Suxibuzone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "The risk or severity of bleeding can be increased when Bumadizone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "The risk or severity of bleeding can be increased when Alminoprofen is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "The risk or severity of bleeding can be increased when Difenpiramide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "The risk or severity of bleeding can be increased when Nifenazone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "The risk or severity of bleeding can be increased when Lonazolac is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "The risk or severity of bleeding can be increased when Tenidap is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "The risk or severity of bleeding can be increased when Propyphenazone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "The risk or severity of bleeding can be increased when Proglumetacin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "The risk or severity of bleeding can be increased when Ethenzamide is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "The risk or severity of bleeding can be increased when Mofebutazone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "The risk or severity of bleeding can be increased when Proquazone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "The risk or severity of bleeding can be increased when Benorilate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "The risk or severity of bleeding can be increased when Pirprofen is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "The risk or severity of bleeding can be increased when Acemetacin is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "The risk or severity of bleeding can be increased when Imidazole salicylate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "The risk or severity of bleeding can be increased when SC 236 is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "The risk or severity of bleeding can be increased when NS 398 is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB14938",
                        "description": "The risk or severity of bleeding can be increased when Flurbiprofen axetil is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "The risk or severity of bleeding can be increased when Loxoprofen is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "Pitolisant may increase the QTc prolonging activities of Anagrelide"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "Anagrelide may increase the QTc prolonging activities of Dronedarone"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "The serum concentration of Anagrelide can be increased when it is combined with Givosiran"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of bleeding can be increased when Sertraline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Anagrelide may increase the vasodilatory activities of Isosorbide mononitrate"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The serum concentration of Anagrelide can be increased when it is combined with Osilodrostat"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB05990",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Obeticholic acid"
                    },
                    {
                        "drugbank-id": "DB11791",
                        "description": "The serum concentration of Anagrelide can be increased when it is combined with Capmatinib"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Anagrelide can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Anagrelide can be decreased when it is combined with Satralizumab"
                    },
                    {
                        "drugbank-id": "DB14845",
                        "description": "The serum concentration of Anagrelide can be increased when it is combined with Filgotinib"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}